92 related articles for article (PubMed ID: 29187298)
1. Regional specificity of matrix metalloproteinase-9 expression in the brain: voxel-level mapping in primary glioblastomas.
Fan X; Qi C; Liu X; Wang Y; Liu S; Li S; Wang L; Wang Y
Clin Radiol; 2018 Mar; 73(3):283-289. PubMed ID: 29187298
[TBL] [Abstract][Full Text] [Related]
2. Anatomical specificity of vascular endothelial growth factor expression in glioblastomas: a voxel-based mapping analysis.
Fan X; Wang Y; Wang K; Liu S; Liu Y; Ma J; Li S; Jiang T
Neuroradiology; 2016 Jan; 58(1):69-75. PubMed ID: 26453565
[TBL] [Abstract][Full Text] [Related]
3. Brain regions associated with telomerase reverse transcriptase promoter mutations in primary glioblastomas.
Fan X; Wang Y; Liu Y; Liu X; Zhang C; Wang L; Li S; Ma J; Jiang T
J Neurooncol; 2016 Jul; 128(3):455-62. PubMed ID: 27230769
[TBL] [Abstract][Full Text] [Related]
4. Identifying radiographic specificity for phosphatase and tensin homolog and epidermal growth factor receptor changes: a quantitative analysis of glioblastomas.
Wang Y; Fan X; Zhang C; Zhang T; Peng X; Qian T; Ma J; Wang L; Li S; Jiang T
Neuroradiology; 2014 Dec; 56(12):1113-20. PubMed ID: 25228449
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas.
Munaut C; Noël A; Hougrand O; Foidart JM; Boniver J; Deprez M
Int J Cancer; 2003 Oct; 106(6):848-55. PubMed ID: 12918061
[TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced magnetic resonance imaging-derived kep as a potential biomarker of matrix metalloproteinase 9 expression in patients with glioblastoma multiforme: a pilot study.
Awasthi R; Pandey CM; Sahoo P; Behari S; Kumar V; Kumar S; Misra S; Husain N; Soni P; Rathore RK; Gupta RK
J Comput Assist Tomogr; 2012; 36(1):125-30. PubMed ID: 22261782
[TBL] [Abstract][Full Text] [Related]
7. Findings of DTI-p maps in comparison with T
Beigi M; Safari M; Ameri A; Moghadam MS; Arbabi A; Tabatabaeefar M; SalighehRad H
Cancer Imaging; 2018 Sep; 18(1):33. PubMed ID: 30227891
[TBL] [Abstract][Full Text] [Related]
8. Anatomical localization of p53 mutated tumors: A radiographic study of human glioblastomas.
Zhang T; Wang Y; Fan X; Ma J; Li S; Jiang T; Wang L
J Neurol Sci; 2014 Nov; 346(1-2):94-8. PubMed ID: 25130928
[TBL] [Abstract][Full Text] [Related]
9. Correlation Between Tumor Location and Clinical Properties of Glioblastomas in Frontal and Temporal Lobes.
Li HY; Sun CR; He M; Yin LC; Du HG; Zhang JM
World Neurosurg; 2018 Apr; 112():e407-e414. PubMed ID: 29355809
[TBL] [Abstract][Full Text] [Related]
10. Computational Identification of Tumor Anatomic Location Associated with Survival in 2 Large Cohorts of Human Primary Glioblastomas.
Liu TT; Achrol AS; Mitchell LA; Du WA; Loya JJ; Rodriguez SA; Feroze A; Westbroek EM; Yeom KW; Stuart JM; Chang SD; Harsh GR; Rubin DL
AJNR Am J Neuroradiol; 2016 Apr; 37(4):621-8. PubMed ID: 26744442
[TBL] [Abstract][Full Text] [Related]
11. Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI.
Bosnyák E; Kamson DO; Robinette NL; Barger GR; Mittal S; Juhász C
J Neurooncol; 2016 Jan; 126(2):317-25. PubMed ID: 26514361
[TBL] [Abstract][Full Text] [Related]
12. Early-Stage Glioblastomas: MR Imaging-Based Classification and Imaging Evidence of Progressive Growth.
Toh CH; Castillo M
AJNR Am J Neuroradiol; 2017 Feb; 38(2):288-293. PubMed ID: 27856439
[TBL] [Abstract][Full Text] [Related]
13. Non-enhancing de novo glioblastoma: report of two cases.
Cohen-Gadol AA; DiLuna ML; Bannykh SI; Piepmeier JM; Spencer DD
Neurosurg Rev; 2004 Oct; 27(4):281-5. PubMed ID: 15449198
[TBL] [Abstract][Full Text] [Related]
14. Quantification of glioblastoma mass effect by lateral ventricle displacement.
Steed TC; Treiber JM; Brandel MG; Patel KS; Dale AM; Carter BS; Chen CC
Sci Rep; 2018 Feb; 8(1):2827. PubMed ID: 29434275
[TBL] [Abstract][Full Text] [Related]
15. Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor.
Toyonaga T; Yamaguchi S; Hirata K; Kobayashi K; Manabe O; Watanabe S; Terasaka S; Kobayashi H; Hattori N; Shiga T; Kuge Y; Tanaka S; Ito YM; Tamaki N
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):611-619. PubMed ID: 27752745
[TBL] [Abstract][Full Text] [Related]
16. Segmentation of peritumoral oedema offers a valuable radiological feature of cerebral metastasis.
Zhou C; Yang Z; Yao Z; Yin B; Pan J; Yu Y; Zhu W; Hua W; Mao Y
Br J Radiol; 2016 Jul; 89(1063):20151054. PubMed ID: 27119727
[TBL] [Abstract][Full Text] [Related]
17. Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival.
Wangaryattawanich P; Hatami M; Wang J; Thomas G; Flanders A; Kirby J; Wintermark M; Huang ES; Bakhtiari AS; Luedi MM; Hashmi SS; Rubin DL; Chen JY; Hwang SN; Freymann J; Holder CA; Zinn PO; Colen RR
Neuro Oncol; 2015 Nov; 17(11):1525-37. PubMed ID: 26203066
[TBL] [Abstract][Full Text] [Related]
18. In vivo MR imaging of folate-receptor expression with the folate-specific nanospheres in a C6 glioblastoma model.
An Y; Tang Q; Yang R; Liu D; Zhang D
Comput Assist Surg (Abingdon); 2017 Dec; 22(sup1):312-318. PubMed ID: 29103327
[TBL] [Abstract][Full Text] [Related]
19. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
20. Expression of adhesion factors and degrading proteins in primary and secondary glioblastomas and their precursor tumors.
Tews DS; Nissen A
Invasion Metastasis; 1998-1999; 18(5-6):271-84. PubMed ID: 10729772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
